InsidersTradesSigma
Total declarations
Companies
▲ Purchases (24 ops.)
▼ Sales (22 ops.)
Insider track record
Board DirectorDisclosed buys
24
Disclosed sells
22
T+90 hit rate
33%
T+90 mean return
-14.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Flynn James E, Director. Director active across 21 companies, notably Werewolf Therapeutics, Inc.. In total, 80 disclosures have been recorded. Split: 24 buys · 22 sells. Total volume traded: €197.3m. Activity tracked since 8 June 2021. The latest transaction was disclosed on 15 July 2026 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Flynn James E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations80 total
5,146 shares@ US$124.000.0065% mcap0.0% of flowClass A Common StockSEC:0001193805-26-000978:3
3,444 shares@ US$124.000.0044% mcap0.0% of flowClass A Common Stock - Restricted Stock UnitsSEC:0001193805-26-000978:5
5,146 shares@ US$124.000.0065% mcap0.0% of flowClass A Common StockSEC:0001193805-26-000978:4
8,299,225 shares@ US$124.0010.52% mcap44.7% of flowClass A Common StockSEC:0001193805-26-000978:0
8,299,225 shares@ US$124.0010.52% mcap44.7% of flowClass A Common StockSEC:0001193805-26-000978:1
650,000 shares@ US$124.000.82% mcap3.5% of flowClass A Common StockSEC:0001193805-26-000978:2
3,444 sharesClass A Common StockSEC:0001193805-26-000845:0
260,992 sharesVoting Common StockSEC:0001193805-26-000798:4
122,990 sharesVoting Common StockSEC:0001193805-26-000798:0
122,990 sharesVoting Common StockSEC:0001193805-26-000798:1
149,238 sharesVoting Common StockSEC:0001193805-26-000798:2
149,238 sharesVoting Common StockSEC:0001193805-26-000798:3
260,992 sharesVoting Common StockSEC:0001193805-26-000798:5
407,132 sharesVoting Common StockSEC:0001193805-26-000798:6
407,132 sharesVoting Common StockSEC:0001193805-26-000798:7
1,084,010 shares@ US$5.0012.7% of flowCommon StockSEC:0001193805-26-000205:0
Canonical exit: 28 May 2026 (T+90)
371,287 shares@ US$95.44521.5% of flowClass A Common StockSEC:0001193805-25-001648:0
3,387,529 shares@ US$3.2030.1% of flowCommon StockSEC:0001193805-25-001155:0
Canonical exit: 29 Oct 2025 (T+90)
370,075 shares@ US$18.4647.3% of flowClass A Common StockSEC:0001193805-25-000959:0
370,074 shares@ US$18.4647.3% of flowClass A Common StockSEC:0001193805-25-000959:1
2,647 shares0Class A Common StockSEC:0001193805-25-000929:0
353,249 shares@ US$0.9306100.0% of flowCommon StockSEC:0001193805-25-000258:0
40,596 shares@ US$17.455.4% of flowClass A Common StockSEC:0001193805-24-001348:0
1,000,000 shares@ US$97.7580.3% of flowClass A Common StockSEC:0001193805-24-001275:0
862,587 sharesCommon StockSEC:0001193805-24-001131:0
25 of 80 declarations
About Flynn James E
Flynn James E is Administrateur and has reported 74 filings in total. Across the 74 sampled recent filings, the period runs from 2016-01-22 to 2026-06-18, with 58,317,086 EUR of buys and 138,986,808 EUR of sells, mainly կապված to Nuvalent, Inc. and Larimar Therapeutics, Inc.
